Consensus statement on renal denervation by the Joint Committee of Japanese Society of Hypertension (JSH), Japanese Association of Cardiovascular Intervention and Therapeutics (CVIT), and the Japanese Circulation Society (JCS)
Cardiovascular Intervention and Therapeutics · 2024
DOI: 10.1007/s12928-024-01017-1 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cardiovascular Intervention and Therapeutics, 2024. Verfasst von Kazuomi Kario und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiovascular Medicine, Jichi Medical University School of Medicine, 3311-1 Yakushiji, Shimotsuke, Tochigi, 329-0498, Japan. kkario@jich…. Hauptthemen laut MEDLINE: Hypertension, Kidney, Sympathectomy. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
This is the first consensus statement of the Joint Committee on Renal Denervation of the Japanese Society of Hypertension (JSH)/Japanese Association of Cardiovascular Intervention and Therapeutics (CVIT)/Japanese Circulation Society (JCS). The consensus is that the indication for renal denervation (RDN) is resistant hypertension or “conditioned” uncontrolled hypertension, with high office and out-of-office blood pressure (BP) readings despite appropriate lifestyle modification and antihypertensive drug therapy. “Conditioned” uncontrolled hypertension is defined as having one of the following: 1) inability to up-titrate antihypertensive medication due to side effects, the presence of complications, or reduced quality of life. This includes patients who are intolerant of antihypertensive drugs; or 2) comorbidity at high cardiovascular risk due to increased sympathetic nerve activity, such as orthostatic hypertension, morning hypertension, nocturnal hypertension, or sleep apnea (unable to use continuous positive airway pressure), atrial fibrillation, ventricular arrythmia, or heart failure. RDN should be performed by the multidisciplinary Hypertension Renal Denervation Treatment (HRT) team, led by specialists in hypertension, cardiovascular intervention and cardiology, in specialized centers validated by JSH, CVIT, and JCS. The HRT team reviews lifestyle modifications and medication, and the patient profile, then determines the presence of an indication of RDN based on shared decision making with each patient. Once approval for real-world clinical use in Japan, however, the joint RDN committee will update the indication and treatment implementation guidance as appropriate (annually if necessary) based on future real-world evidence. Graphical Abstract
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Cardiovascular Medicine, Jichi Medical University School of Medicine, 3311-1 Yakushiji, Shimotsuke, Tochigi, 329-0498, Japan. kkario@jichi.ac.jp.
- Department of Cardiology, Kurume University Medical Center, Fukuoka, Japan.
- Osaka Rosai Hospital, Sakai, Japan.
- Osaka University, Suita, Japan.
- Division of Cardiovascular Medicine, Jichi Medical University School of Medicine, 3311-1 Yakushiji, Shimotsuke, Tochigi, 329-0498, Japan.
- Department of Cardiovascular Medicine, Saga University, Saga, Japan.
Zitieren
APA
Kario, K., Kai, H., Rakugi, H., Hoshide, S., Node, K., Maekawa, Y., Tsutsui, H., Sakata, Y., Aoki, J., Nanto, S., & Yokoi, H. (2024). Consensus statement on renal denervation by the Joint Committee of Japanese Society of Hypertension (JSH), Japanese Association of Cardiovascular Intervention and Therapeutics (CVIT), and the Japanese Circulation Society (JCS). Cardiovascular Intervention and Therapeutics. https://doi.org/10.1007/s12928-024-01017-1
Vancouver
Kario K, Kai H, Rakugi H, Hoshide S, Node K, Maekawa Y, et al. Consensus statement on renal denervation by the Joint Committee of Japanese Society of Hypertension (JSH), Japanese Association of Cardiovascular Intervention and Therapeutics (CVIT), and the Japanese Circulation Society (JCS). Cardiovascular Intervention and Therapeutics. 2024. doi:10.1007/s12928-024-01017-1
BibTeX
@article{Kario2024,
author = {Kario, Kazuomi and Kai, Hisashi and Rakugi, Hiromi and Hoshide, Satoshi and Node, Koichi and Maekawa, Yuichiro and Tsutsui, Hiroyuki and Sakata, Yasushi and Aoki, Jiro and Nanto, Shinsuke and Yokoi, Hiroyoshi},
title = {Consensus statement on renal denervation by the Joint Committee of Japanese Society of Hypertension (JSH), Japanese Association of Cardiovascular Intervention and Therapeutics (CVIT), and the Japanese Circulation Society (JCS)},
journal = {Cardiovascular Intervention and Therapeutics},
year = {2024},
doi = {10.1007/s12928-024-01017-1}
}
EUVIMED